5-fluorouridine has been researched along with Stomach Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, B; Hong, Y; Hu, N; Ji, Z; Li, R; Liu, Q; Song, Z; Wu, F; Wu, P; Yin, JF | 1 |
| Archid, R; Bajaeifer, K; Hack, A; Königsrainer, A; Schott, TC; Weinreich, J | 1 |
2 other study(ies) available for 5-fluorouridine and Stomach Neoplasms
| Article | Year |
|---|---|
Strengthening Gastric Cancer Therapy by Trastuzumab-Conjugated Nanoparticles with Simultaneous Encapsulation of Anti-MiR-21 and 5-Fluorouridine.
Topics: Animals; Antagomirs; Antineoplastic Agents; Cell Line, Tumor; Drug Carriers; Drug Delivery Systems; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; MicroRNAs; Nanoparticles; Polyesters; Receptor, ErbB-2; Stomach Neoplasms; Trastuzumab; Uridine | 2017 |
Growth and Chemosensitivity of Gastric Adenocarcinoma and Non-Malignant Cell Lines in Response to Novel Anti-Cancer Drug Combinations.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Growth Inhibitors; Humans; Stomach Neoplasms; Uridine | 2014 |